We are live on
!
Find out more
TTWM
TCV Trust & Wealth Management Portfolio holdings
AUM
$1.32B
1-Year Est. Return
24.29%
This Fund
S&P 500
This Quarter
Est. Return
+7.88%
1 Year Est. Return
+24.29%
3 Year Est. Return
+68.95%
5 Year Est. Return
+77.67%
10 Year Est. Return
+242.55%
AUM
$823M
AUM Growth
+$50.1M
(+6.5%)
Cap. Flow
-$5.43M
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
27.2%
Holding
201
New
5
Increased
40
Reduced
99
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$7.95M |
| 2 |
iShares AAA-A Rated Corporate Bond ETF
QLTA
|
+$4.21M |
| 3 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
+$962K |
| 4 |
Broadcom
AVGO
|
+$486K |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$470K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$5.94M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.58M |
| 3 |
Microsoft
MSFT
|
+$878K |
| 4 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$718K |
| 5 |
ExxonMobil
XOM
|
+$625K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.83% |
| 2 | Healthcare | 11.61% |
| 3 | Financials | 10.64% |
| 4 | Consumer Staples | 7.92% |
| 5 | Industrials | 7.06% |
Similar funds
MDSL
CC
CP
HCM
MCM
MIM
MRL
B
TCV Trust & Wealth Management's Q4 2019 Portfolio in Review
As of Q4 2019, TCV Trust & Wealth Management held 201 positions worth $823M, up 6.5% from $773M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TCV Trust & Wealth Management's Q4 2019 filing shows 5 new, 40 increased, 99 reduced and 7 closed positions. Its largest new stake was Novartis: 88,654 shares worth $8.39M. The largest sale was GSK, an estimated $5.94M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- TCV Trust & Wealth Management's largest Q4 2019 buy was Novartis: 88,654 shares worth $8.39M.
- TCV Trust & Wealth Management added most to iShares Intermediate Government/Credit Bond ETF in Q4 2019, an estimated $962K increase.
- TCV Trust & Wealth Management's biggest Q4 2019 reduction was GSK, cutting an estimated $5.94M.
- TCV Trust & Wealth Management fully exited GE Aerospace in Q4 2019, selling an estimated $568K.
- TCV Trust & Wealth Management's ten largest holdings make up 27% of its $823M portfolio in Q4 2019.
- TCV Trust & Wealth Management opened 5 new positions and closed 7 in Q4 2019.
- TCV Trust & Wealth Management's portfolio value rose 6.5% quarter-over-quarter to $823M.
Based on TCV Trust & Wealth Management's 13F filing for Q4 2019, filed 6 Feb 2020.